Plain-English translation of NCT01416714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This is a tissue and blood collection study for patients with various digestive cancers — including stomach, esophageal, pancreatic, liver, and colorectal cancers, among others. If you're already having surgery or a biopsy for one of these cancers, researchers are asking to collect and store samples of both normal and cancerous tissue, along with blood samples. These samples will help scientists study how these cancers develop and find better treatments in the future.
Researchers need access to actual cancer tissue and blood from patients to understand how digestive cancers grow and what causes them to develop. By building a large collection of these samples linked to patient information, scientists can study the underlying biology of these diseases and work toward better, more targeted treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will collect samples of tissue (both normal and cancerous) and blood during your already-scheduled surgery or biopsy procedure — so there are no extra surgical visits required. Your samples will be stored and studied to look at genetic changes, protein expression, and other factors that help scientists understand how your cancer develops. Your medical records will also be linked to your samples so researchers can see how the biological findings relate to how your cancer behaves.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States